Hospital Pharmacy Europe - Haematology,

Click here

Saturday 25 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Pharmacy Zone: Haematology

Magazine	Sponsored content
News	Video

Tue 12 Mar

Ruconest: drug evaluation
Recombinant human C1-inhibitor (Ruconest®) has been granted market authorisation in Europe for the treatment of acute...

Thu 31 Jan

Observational study suggests a role for Ferinject®
On the eve of World Cancer Day, Vifor Pharma notes the publication of an observational study in routine oncological and...

Tue 11 Dec
2012

BI to initiate Phase III study in leukaemia
New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company’s...

Mon 3 Dec
2012

New data on Bayer’s Xarelto®
Bayer HealthCare announced that new data from the clinical development programme for its oral anticoagulant Xarelto®...

Wed 28 Nov
2012

Bayer completes recruitment of first cohort
Bayer's BAY 86-6150 is being investigated in a Phase II/III study called TRUST (Treatment with Unique recombinant FVII STudy) and...

Wed 28 Nov
2012

Novartis highlights key data
Novartis will highlight more than 140 presentations on key data from its extensive oncology portfolio at the leading year-end...

Wed 28 Nov
2012

Exembol® for HIT now available in the UK
Mitsubishi Pharma Europe has announced the UK launch of Exembol® (argatroban), indicated for anticoagulation in adult...

Mon 19 Nov
2012

Novartis drug Exjade® recommended by CHMP
Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...

Wed 17 Oct
2012

ScIg replacement for antibody deficiencies
To reduce the risk of infection in patients with primary immunodeficiencies, replacement therapy with immunoglobulin is required....

Mon 18 Jun
2012

EHA: Ponatinib results set PACE for approval
Data presented at the European Haematology Association Annual Congress show robust anti-leukaemic activity

Wed 18 Jan
2012

Primary prophylaxis 'also effective for adult haemophiliacs'
Preventive haemophilia A treatment reduces annual bleeding events and frequency of infusions

Mon 19 Dec
2011

NEJM study finds leukaemia DNA mutations
Results may target treatment decisions in chronic lymphocytic leukaemia

Mon 26 Sep
2011

EMA recommends Rasitrio® for high blood pressure
Matter referred to the European Commission and final decision expected in three months

Thu 21 Jul
2011

IL-2 monotherapy 'not effective' as acute AML therapy
'Blood' journal claims Interleukin-2 won't help patients in first complete remission

Mon 27 Jun
2011

Linagliptin effective as glimepiride, fewer CV events
Two-year Phase III study confirms linagliptin has significant efficacy and good tolerability in combination therapy with metformin

Fri 3 Jun
2011

New treatment hope for diabetes and cardiovascular diseases
New research at the University of Leicester to contribute to more effective drug design

Fri 20 May
2011

Supplements 'prevent pre-eclampsia'
Pregnant women could reduce their risk of pre-eclampsia by taking dietary supplements

Mon 16 May
2011

Sickle cell drug 'safe for infants'
A sickle cell anaemia drug is safe for use in children and should be made available

Web design, hosting and programming by ModeZero